Response to "Depression and Adherence to Antihypertensive Therapy (original) (raw)
American Journal of Hypertension
AI-generated Abstract
This response addresses the comments made by Eze-Nliam et al. regarding the relationship between depression and adherence to antihypertensive therapy. While acknowledging depression as a potential determinant of nonadherence, the author highlights the limitations of current studies, particularly regarding selection and information bias. Objective measures of adherence, such as the medication possession ratio (MPR), are emphasized over self-reported adherence. The author calls for further investigation into the impact of depression screening on treatment adherence and announces a longitudinal cohort study aimed at resolving these pertinent questions.
Loading Preview
Sorry, preview is currently unavailable. You can download the paper by clicking the button above.